Thyrocare Technologies Ltd.
| BSE: 539871 | Sector: Health care |
| NSE: THYROCARE | ISIN Code: INE594H01019 |
| BSE 12:27 | 28 Jan | 1043.50 |
-15.95 (-1.51%) |
OPEN
1059.45 |
HIGH
1059.45 |
LOW
1009.15 |
| NSE 12:19 | 28 Jan | 1043.65 |
-13.40 (-1.27%) |
OPEN
1046.50 |
HIGH
1054.00 |
LOW
1010.00 |
| OPEN | 1059.45 |
| PREVIOUS CLOSE | 1059.45 |
| VOLUME | 8521 |
| 52-Week high | 1465.90 |
| 52-Week low | 832.00 |
| P/E | 30.93 |
| Mkt Cap.(Rs cr) | 5,520 |
| Buy Price | 1043.65 |
| Buy Qty | 1.00 |
| Sell Price | 1044.95 |
| Sell Qty | 10.00 |
Thyrocare Technologies Ltd. (THYROCARE) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 631.30 | 21.90 | 3.59 | 15823.68 |
| Cipla | 939.05 | 11.20 | 1.21 | 13900.58 |
| Dr Reddy's Labs | 4340.00 | 83.55 | 1.96 | 13349.10 |
| Sun Pharma.Inds. | 838.10 | 25.90 | 3.19 | 12803.21 |
| Lupin | 907.40 | 19.30 | 2.17 | 11055.93 |
| Apollo Hospitals | 4556.40 | 262.90 | 6.12 | 9153.00 |
| Cadila Health. | 399.95 | 16.00 | 4.17 | 7790.40 |
| Glenmark Pharma. | 494.30 | 17.95 | 3.77 | 7567.93 |
| Alkem Lab | 3416.20 | 36.65 | 1.08 | 7219.68 |
| Divi's Lab. | 4045.65 | 104.25 | 2.64 | 6798.61 |
| Torrent Pharma. | 2702.00 | 49.85 | 1.88 | 6450.83 |
| Ipca Labs. | 1016.35 | 9.20 | 0.91 | 5114.11 |
| Alembic Pharma | 750.65 | 13.85 | 1.88 | 5051.44 |
| Laurus Labs | 481.50 | 17.70 | 3.82 | 4768.72 |
| Abbott India | 16281.95 | 60.60 | 0.37 | 4310.02 |
| Gland Pharma | 3379.60 | 3.35 | 0.10 | 3462.88 |
| Glaxosmi. Pharma | 1617.25 | -16.80 | -1.03 | 3193.74 |
| Granules India | 305.15 | 11.05 | 3.76 | 3134.98 |
| Sanofi India | 7298.20 | 294.00 | 4.20 | 2901.90 |
| Ajanta Pharma | 2245.95 | 39.75 | 1.80 | 2718.59 |
Quick Links for Thyrocare Technologies:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
